FDA Alerts Archive

Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals – Adverse Events After Receiving Eye Injections

June 15, 2018 Print this page AUDIENCE: Patient, Health Professional, Eye Care, Risk Manager ISSUE:  At least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients reportedly …

Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall – Due to the Potential Presence of Particulate Matter

June 4, 2018 Print this page AUDIENCE: Pain Management, Pharmacy, Anesthesiology, Emergency Medicine, HealthProfessional    ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, …